Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide with Peg-IFN and Ribavirin in HIV/HCV Co-infection
NCT01185028Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- Aug 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in hepatitis C virus infection, sponsored by National Institutes of Health. Started Aug 2010; status: completed.
02
Drugs
nitazoxanide
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01185028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185028.